- Page 2 of 2

About

Science journalist at Labiotech.eu. Born half Kiwi, half German. I have a BSc in Biology and an MSc in Science Communication from different Universities. I love writing, painting and eating chocolate. Sometimes, I share.

Articles by Larissa Warneck-Silvestrin

Reports 2 Jul 2020

Guidelines for Biotechs: Managing Risks in Biological Drug Development

Navigating the complexity of the industry can be highly challenging for early-stage biotechs focusing on biological drug development. Once they have a robust strategy in place and have chosen a suitable partner, biotechs face other hurdles in upstream process development, manufacturing, IND filing, and regulatory processes. Discover how to address challenges and manage risks throughout […]

July 2, 2020 - 2 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 27 May 2020

Why Listening to Patient Organizations is Key in Drug Development

As the biotech industry flourishes and therapies become more targeted and personalized, the need for drug developers to interact with patients is increasing as well. While patient organizations took a backseat in the past, they are continuously gaining importance in drug development today. Nowadays, talking with patient organizations has become paramount for successful drug development, […]

May 27, 2020 - 11 minutesmins - By Larissa Warneck-Silvestrin

Interview 15 Apr 2020

Investing in the Microbiome in the Age of Covid-19 and Beyond

For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to be an important year for microbiome research. However, the global coronavirus pandemic arrived, presenting one of the greatest unforeseen challenges in human history. I spoke to her about the microbiome field’s progress and the legacy of the Covid-19 pandemic going […]

April 15, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Best in Biotech 24 Feb 2020

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

With the success of CAR T-cell therapies and other innovative medicines in this area, immuno-oncology has become a buzzword in biotech, with more and more companies starting up in Europe and elsewhere. With so many players involved, it can be hard to know who is doing what. Here are 20 European companies we think stand […]

February 24, 2020 - 12 minutesmins - By Larissa Warneck-Silvestrin

Interview 12 Feb 2020

Boosting Cancer Research by Unlocking Genomic Data

More genomic data is produced today than ever before as it’s fundamental to the development of new medicines. But although there is a lot of data out there, much of it is inaccessible. With a background in computer science and bioinformatics, Fiona Nielsen, co-founder and CEO of Repositive, decided to overcome this bottleneck and open […]

February 12, 2020 - 6 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 12 Dec 2019

Tips & Tricks for Social Media in the Life Sciences

With social media, as with many industries, you have to make sure to stay on top of the game. The phrase ‘if you snooze, you lose’ remains as true as ever. If you don’t jump on the bandwagon now, you might be in for a bad surprise later. We don’t want you to miss out, […]

December 12, 2019 - 14 minutesmins - By Larissa Warneck-Silvestrin

How can Proteomics Boost the Discovery of Novel Drugs and Biomarkers?

Proteins, the key players within cells. They carry out enzymatic functions, are involved in signaling cascades, contribute to the structure of cells, and much, much more. Their abundance and intricate functions make the study of the proteome highly complex. However, once decoded, proteins can be highly useful for the discovery and development of novel therapies, […]

October 28, 2019 - 8 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 12 Sep 2019

Interview: The Do’s & Don’ts of Branded Content in the Life Sciences Industry

Although it’s becoming increasingly popular in life science marketing, branded content is still in its infancy. This does not mean it isn’t worth investing in. Quite the contrary: because it is fairly new, it is all the more exciting and can reach promising audiences within the life sciences industry. While other industries have long since […]

September 12, 2019 - 12 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 1 Aug 2019

How to Use Case Studies to Take Your Life Science Marketing Strategy to the Next Level

To build a great relationship with a business partner, laying a foundation of trust is essential. But how can a potential partner trust you if they have no concept of how you work? Case studies can help communicate trust and show your potential partner how they can improve their life science marketing strategy by working […]

August 1, 2019 - 6 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 16 May 2019

Avoid These Pitfalls When Creating a Life Sciences White Paper

If you are looking for a way to educate your readers on a specific topic while collecting valuable leads at the same time, a white paper might just be the way to go. With a typical length of at least six pages, white papers are long-form content pieces about specialized topics, such as individual markets […]

May 16, 2019 - 12 minutesmins - By Larissa Warneck-Silvestrin

HEADER 01 blog post Konstantin Kolosov 1

Expert Advice 16 Apr 2019

How to Outsource Your Content Creation Process to a Life Science Writer

For many people, the mere thought of having to write a content piece comprising more than 200 words is daunting. In the life sciences, as in other industries, writing requires a specific skill set and uses time and energy which are often needed for other important tasks. In these situations, it can be helpful to […]

April 16, 2019 - 9 minutesmins - By Larissa Warneck-Silvestrin

Top 5 Things to Know About Immunotherapies – A Review

Immunotherapy – A big word with much meaning. There’s no use in talking about their history. The fact that immunotherapies seem to be the next big thing in biotech is reason enough to discuss them. For this purpose, we have caught up with Etienne Drouet, Vice President of Strategic Development at SynteractHCR, an international CRO. […]

November 13, 2017 - 13 minutesmins - By Larissa Warneck-Silvestrin

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Larissa Warneck-Silvestrin

About

Articles by Larissa Warneck-Silvestrin

Guidelines for Biotechs: Managing Risks in Biological Drug Development

Why Listening to Patient Organizations is Key in Drug Development

Investing in the Microbiome in the Age of Covid-19 and Beyond

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

Boosting Cancer Research by Unlocking Genomic Data

Tips & Tricks for Social Media in the Life Sciences

How can Proteomics Boost the Discovery of Novel Drugs and Biomarkers?

Interview: The Do’s & Don’ts of Branded Content in the Life Sciences Industry

How to Use Case Studies to Take Your Life Science Marketing Strategy to the Next Level

Avoid These Pitfalls When Creating a Life Sciences White Paper

How to Outsource Your Content Creation Process to a Life Science Writer

Top 5 Things to Know About Immunotherapies – A Review

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Larissa Warneck-Silvestrin

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!